Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: β192P A multicenter crossover analysis of first and second-line FOLFIRINOX or gemcitabine plus nab-paclitaxel administered to pancreatic cancer patients: Results from the NAPOLEON studyβ.
Haruo Iguchi, Mototsugu Shimokawa, Tsuyoshi Shirakawa, F. Koga, Yujiro Ueda +14 more
Jian Zhou, John L. Schuzer, Masakazu Matsuura, Takuya Nemoto, Hiroki Taguchi +3 more